Pricing Log in Create free account

Inventiva S.A. Sponsored ADR (IVA) vs Lexicon Pharmaceuticals, Inc. (LXRX)

Inventiva S.A. Sponsored ADR and Lexicon Pharmaceuticals, Inc. are both Biotechnology companies. Inventiva S.A. Sponsored ADR and Lexicon Pharmaceuticals, Inc. are of similar size ($740.0M and $734.2M). Inventiva S.A. Sponsored ADR grew revenue faster over the last twelve months: 547.9% against −29.0%. Lexicon Pharmaceuticals, Inc. has the higher net margin (−147.4% vs −750.3%) and the lower return on invested capital (−96.4% vs 0.00%). Across the 18 metrics below, Inventiva S.A. Sponsored ADR leads on 10 and Lexicon Pharmaceuticals, Inc. on 8.

Valuation

Metric IVA LXRX Biotechnology median
P/E n/m n/m 8.50
P/S 5.79 16.04 9.71
P/B 1.66 3.81 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.01 n/m 0.64
EV/Sales (0.10) 12.80 9.21
Earnings yield (121.19%) (10.04%) (33.15%)
Free cash flow yield (120.95%) (9.92%) (25.50%)

Profitability

Metric IVA LXRX Biotechnology median
Gross margin 0.00% 99.14% 65.16%
Operating margin 0.00% (131.43%) 0.00%
Net margin (750.28%) (147.38%) 0.00%
Free cash flow margin 0.00% (156.71%) 0.00%
Return on equity 0.00% (40.21%) (56.36%)
Return on assets 0.00% (25.70%) (48.04%)
Return on invested capital 0.00% (96.36%) 0.00%

Growth

Metric IVA LXRX Biotechnology median
Revenue growth (TTM) 547.89% (29.03%) 6.02%
EPS growth (last fiscal year) 35.44% 77.78% 30.26%
Revenue growth, 5-year CAGR 8.33% 15.72% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IVA LXRX Biotechnology median
Debt to equity 1.13 0.29 0.00
Current ratio 3.81 13.37 4.72
Net debt to EBITDA 0.29 0.91 0.96

Dividend

Metric IVA LXRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IVA LXRX Biotechnology median
Market cap 739.99m 734.18m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack